At Mindspace, ketamine treatment is only available to individuals between the ages of 18 and 65, and to Quebec residents. At present, youth under 18 years of age, pregnant women and nursing mothers are not eligible for ketamine treatment, since the effects of ketamine on pregnancy, nursing children and youth are still relatively unknown. Though research indicates that ketamine treatment may be effective for a number of mental health indications, Mindspace is currently focused on addressing treatment-resistant depression.
To be eligible for ketamine treatment for depression, you must be evaluated by a medical practitioner and not have any contraindications to this therapy, including any medical or other psychiatric illnesses that suggest this treatment might be unsafe. Conditions that may make you ineligible for ketamine treatment include, but are not limited to: a history of psychosis (e.g. hallucinations), mania, untreated hypertension, heart disease or stroke, and seizure. Similarly, severe liver disease, untreated thyroid disorders or other medical conditions may require management prior to ketamine treatment.
If you are suffering from treatment-resistant depression our team will work directly with you to determine whether you are a good candidate for treatment by taking a full medical and psychological history.
